PLYMOUTH MEETING, Pa., Oct. 30 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP - News; "BMP Sunstone" or the "Company"), today announced it will participate in the following conferences:
-- Oppenheimer 20th Annual Healthcare Conference, to be held November 3-4,
2009 at the Waldorf=Astoria hotel in New York. Management is scheduled
to present at 3:20 pm ET on Tuesday, November 3, and meet with
institutional investors throughout the day. A live webcast of the
presentation will be available via the Company's website at
http://www.bmpsunstone.com .
-- Brean Murray, Carret & Co. 2009 China Growth Conference, to be held
November 19-20, 2009 at the Millennium Broadway hotel in New York.
Management is scheduled to present at 3:40 pm ET on Thursday, November
19, and meet with institutional investors throughout the day.
For further details, please contact your respective institutional sales representative.
About BMP Sunstone Corporation
BMP Sunstone Corporation ("BMP Sunstone" or the "Company") is a specialty pharmaceutical company that is building a proprietary portfolio of branded pharmaceutical and healthcare products in China. Through Sunstone Pharmaceutical Co. Ltd., the Company manufactures leading pediatric and women's health products, including two of China's most recognized brands, "Hao Wawa" and "Confort," sold throughout the country in approximately 120,000 pharmacies. The Company also markets a portfolio of products under exclusive multi-year licenses into China, primarily focused on women's health and pediatrics, as well as provides pharmaceutical distribution services through subsidiaries in Beijing and Shanghai. BMP Sunstone's main office is in Beijing, with a U.S. office in Plymouth Meeting, PA. For more information, please visit http://www.bmpsunstone.com .
For further information, please contact:
Integrated Corporate Relations, Inc.
(Investor Relations)
Ashley M. Ammon
Tel: +1-646-277-1200
Christine Duan
Tel: +1-203-682-8200
Copyright © 2009 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.